Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Biomarkers analysis
Improve the success rate of your drug development program with a well-designed biomarker program, enabling precision medicine approaches by molecular characterization of clinical samples.
Biomarkers play a critical role in all phases of drug development by providing critical information on pharmacodynamics, efficacy and safety. A well planned and executed biomarker plan, together with a robust understanding of your patient population, will take you closer to the final goal of evaluating the clinical potential of your lead compound or candidate drug.
We have extensive experience with the use of biomarkers for many different purposes in drug development, including target engagement, proof of mechanism (PoM), proof of principle (PoP), proof of concept (PoC) and precision medicine/patient stratification. We can help you with your Biomarker Plan and Translational Medicine Plan, which will provide clarity and line-of-sight and also help you to address critical questions and answers at the right time in your pre-clinical drug development process.
Truly offers fully equipped labs capable of analyzing samples spanning from preclinical bioanalysis to clinical samples. We customize assays to your specific needs and our experienced team will work together with you to determine, develop, and run the optimal assays for your studies and projects. We routinely develop or transfer, optimize, and apply quantitative bioanalytical methods to measure drug and metabolite concentrations for samples in most biological fluids, including standard plasma, serum, tissue and saliva.
